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Placental Morphology Is Associated 
with Maternal Depressive 
Symptoms during Pregnancy and 
Toddler Psychiatric Problems
Marius Lahti-Pulkkinen  1,2,3, Melissa Jane Cudmore2, Eva Haeussner4, Christoph Schmitz  4, 
Anu-Katriina Pesonen1, Esa Hämäläinen5, Pia M. Villa6, Susanna Mehtälä7, Eero Kajantie3,8,9, 
Hannele Laivuori  7,10,11,12, Rebecca M. Reynolds2, Hans-Georg Frank4 & Katri Räikkönen1
Maternal depressive symptoms during pregnancy predict increased psychiatric problems in children. 
The underlying biological mechanisms remain unclear. Hence, we examined whether alterations in 
the morphology of 88 term placentas were associated with maternal depressive symptoms during 
pregnancy and psychiatric problems in 1.9–3.1-years old (Mean = 2.1 years) toddlers. Maternal 
depressive symptoms were rated biweekly during pregnancy with the Center of Epidemiological Studies 
Depression Scale (n = 86). Toddler psychiatric problems were mother-rated with the Child Behavior 
Checklist (n = 60). We found that higher maternal depressive symptoms throughout pregnancy 
[B = −0.24 Standard Deviation (SD) units: 95% Confidence Interval (CI) = −0.46; −0.03: P = 0.03; Mean 
difference = −0.66 SDs; 95% CI = −0.08; −1.23: P = 0.03; between those with and without clinically 
relevant depressive symptoms] were associated with lower variability in the placental villous barrier 
thickness of γ-smooth muscle actin-negative villi. This placental morphological change predicted 
higher total (B = −0.34 SDs: 95% CI = −0.60; −0.07: P = 0.01) and internalizing (B = −0.32 SDs: 
95% CI = −0.56; −0.08: P = 0.01) psychiatric problems in toddlers. To conclude, our findings suggest 
that both maternal depressive symptoms during pregnancy and toddler psychiatric problems may be 
associated with lower variability in the villous membrane thickness of peripheral villi in term placentas. 
This lower heterogeneity may compromise materno-fetal exchange, suggesting a possible role for 
altered placental morphology in the fetal programming of mental disorders.
Maternal clinically relevant depressive symptoms complicate up to 10–20% of pregnancies1–5. Maternal depres-
sive symptoms not only disrupt the health of the pregnant woman4,6 but also have adverse consequences on 
offspring mental health2,3,7–9. Several studies have shown that maternal depressive symptoms during pregnancy 
predict increased psychiatric problems in offspring, and these effects are not explained by maternal depressive 
symptoms after pregnancy2,3,7–9. For example, we showed among 2296 Prediction and Prevention of Preeclampsia 
and Intrauterine Growth Restriction (PREDO)-study participants that maternal depressive symptoms during 
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pregnancy predict increased psychiatric problems in children, independently of maternal depressive symptoms 
after pregnancy3. However, the biological mechanisms underlying these associations remain largely unknown.
Emerging evidence suggests that maternal depressive symptoms during pregnancy may alter maternal 
physiological homeostasis above and beyond alterations induced by the pregnancy itself, leading to changes in 
hypothalamic-pituitary-adrenocortical axis, inflammatory and autonomic nervous system functioning, and in 
oxidative stress and nutrition levels2,6,9–14. These depression-related physiological changes may alter the normal 
placental adaptation and remodelling which occurs to ensure that the requirements for oxygen, hormones, nutri-
ents and waste removal of the growing fetus are met throughout gestation15.
Aberrations in placental development and maturation that adversely affect the capacity of the placenta to 
provide optimal materno-fetal exchange can influence fetal health and program the fetus for disease development 
later in life16,17. A mature placenta comprises an extensive villous tree containing a network of fetal capillar-
ies that bathes in a pool of maternal blood18. The villous tree consists of large structural stem villi that arbo-
rize to form intermediate and terminal villi, with a γ-smooth muscle actin(SMA)-positive perivascular layer of 
myofibroblast-like cells that aborize in the (then myofibroblast-free and SMA-negative) peripheral part of the 
villous tree19. This peripheral part of the villous tree facilitates most materno-fetal exchange20. The whole villous 
tree is covered by a principally bi-layered epithelium with an at-term largely incomplete basal layer of cytotroph-
oblasts and an apical layer, called the syncytiotrophoblast. The layers from the apical aspect of the syncytiotropho-
blast to the apical (luminal) surface of the fetal capillary endothelium constitute the placental villous membrane21, 
the villous materno-fetal barrier15. As pregnancy progresses and fetal demand for gaseous and nutrient exchange 
increases, the villous membrane thickness becomes irregular22. Some areas become extremely thin as locally 
dilated segments of fetal capillaries protrude into the trophoblast layer and some areas remain thicker, where 
syncytial organelles and nuclei accumulate outwith these thin barrier areas18,23. The areas of extremely thin vil-
lous membrane, as small as 1–2 microns, are known as vasculo-syncytial membranes (VSM) and are the primary 
materno-fetal exchange sites24. Thus, a healthy late gestation placenta has high variability in villous membrane 
thickness measures and hence diffusion distance evidenced by larger standard deviations (SD:s)25. Increased VSM 
thickness and a resulting decrease in villous membrane thickness variability has been shown in placentas from 
pregnancies complicated by preeclampsia26 and gestational diabetes27.
Previous studies have shown that maternal psychological distress during pregnancy may be associated with 
altered placental weight and fetoplacental circulation28,29, and alterations in placental weight and/or surface area 
may predict psychiatric disturbance in childhood and adolescence30, and certain personality disorders31 and 
traits32 in adulthood. Yet, no previous studies have tested associations between maternal depressive symptoms 
or child psychiatric problems and placental morphology. In this hypothesis-generating study, we tested whether 
maternal depressive symptoms during pregnancy are associated with alterations in the morphology of term pla-
centas, and if term placental morphology predicts child psychiatric problems in toddlerhood.
Results
Participant Characteristics and Potential Confounders. Table 1 shows the sample characteristics. In 
our study sample, maternal depressive symptoms showed high inter-individual stability across pregnancy trimes-
ters (r’s from =0.63 to =0.84, P < 0.001). Toddler internalizing, externalizing and total psychiatric problems also 
had high inter-correlations (r’s from =0.63 to =0.88, P < 0.001). Supplementary Table S1 shows the intercorrela-
tions between the different placental morphology indicators.
Maternal diabetic and hypertensive disorders in pregnancy were associated with smaller capillary volumes 
per SMA-positive villi per placenta (Mean Difference (MD) = 0.56: 95% Confidence Interval (CI) = 0.00;1.12: 
P = 0.05). Girls had larger capillary volumes per SMA-negative villi per placenta than boys (MD = 0.41: 
95%CI = 0.01;0.81: P = 0.05). Gestation length was positively associated with volumes of SMA-negative 
villi (r = 0.24; P = 0.02) and capillaries per SMA-negative villi (r = 0.27; P = 0.01) per placenta. Maternal age, 
pre-pregnancy body mass index (BMI), education, or history of mental disorders before pregnancy were not 
associated with placental morphology (P-values ≥ 0.10).
Maternal Depressive Symptoms during Pregnancy and Placental Morphology. Higher mater-
nal depressive symptoms throughout pregnancy (Table 2) and during each pregnancy trimester (Table 3) were 
associated with a significantly smaller SD of the villous barrier thickness of SMA-negative villi (indicating less vil-
lous barrier thickness variability) in unadjusted and/or adjusted regression analyses. Figure 1 shows that similar 
associations with a smaller SD of SMA-negative villi villous barrier thickness were found when CES-D depressive 
symptoms throughout pregnancy were above the clinical cutoff score (Panel A), and when these symptoms were 
more frequently above the cutoff during pregnancy trimesters (Panel B). The associations with this placental 
morphology indicator were most consistent across analytic models for maternal depressive symptoms during the 
first pregnancy trimester (Table 3).
Placental Morphology and Child Psychiatric Problems. A smaller SD of the villous barrier thickness 
of SMA-negative villi predicted significantly higher toddler total and internalising psychiatric problems in unad-
justed and adjusted regression models (Table 4). A smaller SD of SMA-negative villi villous barrier thickness also 
predicted higher toddler sleep, affective, anxiety, anxious/depressed, emotionally reactive, pervasive developmen-
tal and oppositional defiant problems in unadjusted and/or adjusted regression models (Supplementary Table S2).
Discussion
This explorative, hypothesis-generating study examined whether maternal depressive symptoms during preg-
nancy and subsequent toddler psychiatric problems were associated with morphology alterations of term pla-
centas. We found that both maternal depressive symptoms across pregnancy and toddler total and internalizing 
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psychiatric problems were associated with less variation in SMA-negative villi villous barrier thickness, suggest-
ing an association with placental maturation. These associations were independent of several maternal and tod-
dler sociodemographic and perinatal characteristics. The associations of maternal depressive symptoms with 
placental morphology were the most consistent for depressive symptoms during the first pregnancy trimester, 
and they were also independent of maternal history of physician-diagnosed mental disorders before pregnancy. 
The associations of placental morphology with toddler psychiatric problems were also independent of maternal 
depressive symptoms concurrently to child assessment.
The villous barrier is the physical barrier through which maternal-fetal exchange of gases, nutrients and waste 
occurs. Its thickness directly correlates with exchange efficiency, thus it is a highly relevant physiological measure-
ment. As gestation progresses the exchange demands placed on this barrier increase and the villous barrier of the 
SMA-negative villi becomes more heterogeneous in thickness. Fetal capillaries, especially their sinusoidal vessels 
in the terminal segments of the villous tree23, dilate into anuclear areas of the syncytium leading to areas of the 
villous barrier that are extremely thin to maximize exchange efficiency24. However, to accommodate these areas of 
Maternal Characteristics
Data 
Available(N) Mean(SDa)/N(%)
Age at Delivery (years) 88 31.5 (4.9)
Education, Tertiary 88 57 (64.8%)
Pre-Pregnancy Body Mass Index (kg/m2) 88 24.0 (4.2)
Any Diabetic or Hypertensive Disorder in Pregnancy (type 1 or gestational diabetes, chronic or 
gestational hypertension, pre-eclampsia), Yes 88 15 (17.0%)
History of Physician-Diagnosed Mental Disorders Before Pregnancy, Yes 80 13 (16.3%)
Depressive Symptoms
   Trimester-Weighted Mean Score of Center for Epidemiological Studies 86 10.3 (6.0)
Depression Scale Depressive Symptoms during Pregnancy
   Trimester-Weighted Mean Score of Center for Epidemiological Studies 86 14 (16.3%)
Depression Scale Depressive Symptoms during Pregnancy ≥ 16
   1st Pregnancy Trimester Center for Epidemiological Studies Depression 81 10.2 (6.7)
Scale Depressive Symptom Score
   Mean of 2nd Pregnancy Trimester Center for Epidemiological Studies 86 10.4 (6.5)
Depression Scale Depressive Symptom Scores
   Mean of 3rd Pregnancy Trimester Center for Epidemiological Studies 86 10.3 (6.6)
Depression Scale Depressive Symptom Scores
   Number of Pregnancy Trimesters with Center for Epidemiological Studies 81
     0 53 (65.4%)
     1 16 (19.8%)
     2–3 12 (14.8%)
Beck Depression Inventory-II Score Concurrently to Rating the Child 60 5.9 (5.5)
Placental Morphology
Volume of SMAb-Positive Villi per Placenta (ml) 88 95.1 (50.9)
Volume of Capillaries per SMA-Positive Villi per Placenta (ml) 88 56.0 (35.6)
Volume of SMAb-Negative Villi per Placenta (ml) 88 182.7 (63.9)
Volume of Capillaries per SMAb-Negative Villi per Placenta (ml) 88 157.5 (51.8)
Ratio of the Distribution of SMAb-Positive Villi to SMA-Negative Villi (%) 88 63.7 (56.8)
Villous Barrier Thickness of SMAb-Positive Villi (µm) 88 7.5 (1.7)
Standard Deviation of Villous Barrier Thickness of SMAb-Positive Villi (Variability in Thickness) (µm) 88 6.3 (2.3)
Villous Barrier Thickness of SMAb-Negative Villi (µm) 88 11.9 (4.6)
Standard Deviation of Villous Barrier Thickness of SMAb-Negative Villi (µm) 88 10.2 (5.5)
Placental Weight (grams) 88 589.7 (107.4)
Toddler Characteristics
Gestation Length (weeks) 88 40.3 (1.0)
Sex 88
       Boys 41 (46.6%)
       Girls 47 (53.4%)
Age at Follow-up (months) 60 25.5 (2.9)
Child Behavior Checklist/1½-5 Psychiatric Problems
Total Problems 60 46.8 (9.2)
Internalizing Problems 60 45.4 (8.5)
Externalizing Problems 60 48.6 (9.4)
Table 1. Characteristics of the Study Sample. aSMA = γ-smooth muscle actin. bSD = standard deviation.
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thinning, syncytiotrophoblastic organelles accumulate in thicker areas outwith the VSMs, called syncytial knots33. 
Thus, an irregularity in villous barrier thickness develops and its appearance indicates optimal placental matura-
tion. According to previous findings the development of VSMs and syncytial knots decrease diffusion resistance 
by 26%, compared with that of a barrier with uniform thickness34 and there is an inverse relationship between 
the number of VSMs and fetal hypoxia26. Analysis of uncomplicated full-term placentas showed that although 
absolute villous barrier thickness measurements varied between different placentas, the uniformity index (a ratio 
between the thick and thin villous barrier areas) was relatively constant from one placenta to another34. This indi-
cates that there is likely an optimal irregularity of the villous barrier to maximally and optimally serve the growing 
fetus. Our data showing that less heterogeneity in placental villous barrier thickness is associated with maternal 
depressive symptoms could point to a mechanism whereby maternal depression-related changes cause subtle 
alterations in placental maturation, especially in the dynamic villous trophoblast layers. This may compromise 
the efficiency and robustness of materno-fetal exchange (diffusion controlled transport in thinned membrane 
areas and actively supported transport in thicker areas), which then affects fetal neurodevelopment, leading to 
psychiatric problems in toddlers. Among villous trophoblast layers, the most important for this finding could 
be the syncytiotrophoblast, which is the epithelium at the materno-fetal border and can be considered a steady 
state structure in a vulnerable sandwich position between cytotrophoblast proliferation and syncytial shedding35.
While maternal diabetes or hypertension in pregnancy did not explain the associations of placental mor-
phology with maternal or toddler psychopathology, placentas from diabetic or hypertensive pregnancies had 
smaller vessel volumes in SMA-positive villi. The vessels within the SMA-positive villi are the fundamental con-
duits of blood supply from fetus to the SMA-negative peripheral part of the villous tree, which are the primary 
sites of materno-fetal exchange15. Any reduction in vessel volume within the more centrally located and larger 
SMA-positive villi would result in suboptimal blood supply to peripheral villi and hence compromised fetal nutri-
ent and oxygen supply and waste removal15. Although the villous barrier thickness and hence the diffusing capac-
ity of the barrier is unaltered in pregnancies with diabetic or hypertensive disorders36,37, if the carrying capacity of 
stem villi capillaries is compromised due to their scarceness, a deficient exchange may ensue due to blood supply 
from the fetus being limited by the suboptimal stem villi vessel volume.
Figure 1. (A) Maternal clinically significant antenatal depressive symptoms and placental SMA-negative villi 
villous barrier thickness variability. The figure shows the unadjusted mean values and 95% Confidence Intervals 
of the standard deviation of placental SMA-negative villi villous barrier thickness (in standard deviation units) 
for mothers with trimester-weighted mean antenatal depressive symptoms below or above the clinical cutoff 
of ≥16 points. P-values refer to group difference significances from unadjusted linear regression models (model 
1), models adjusted for maternal age, education, pre-pregnancy BMI, hypertensive and diabetic disorders 
in pregnancy and gestation length (model 2), and models adjusted also for maternal history of physician-
diagnosed mental disorders before pregnancy (model 3). (B) Maternal accumulative depressive symptoms 
during pregnancy and SMA-negative villi villous barrier thickness variability. The figure shows the unadjusted 
mean values and 95% Confidence Intervals of the standard deviation of SMA-negative villi villous barrier 
thickness in standard deviation units, according to the number of pregnancy trimesters [0, 1, 2–3] maternal 
depressive symptom scores during pregnancy were above the clinical cutoff of ≥16, when calculated from the 
value at the first trimester and mean values across second and third trimesters. P-values refer to the significances 
of group differences and linear trends from unadjusted linear regression models (model 1), models adjusted for 
maternal age, education, pre-pregnancy BMI, hypertensive and diabetic disorders in pregnancy and gestation 
length (model 2), and models adjusted also for maternal history of physician-diagnosed mental disorders before 
pregnancy (model 3).
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The limitations of our study include the small sample size and use of only maternal reports of maternal depres-
sive symptoms and toddler psychiatric problems. The sample size was 86 for the analyses on maternal depressive 
symptoms during pregnancy and placental morphology, and only 60 for the analyses on placental morphology 
and toddler psychiatric problems. Hence, there is a possibility for chance findings, and our findings need to be 
replicated in larger study samples.
Furthermore, attrition analyses suggested that some key characteristics of the study sample may be associated 
with study attrition, which may limit the generalizability of our findings. Since the women participating in the 
current study scored lower on antenatal depressive symptoms than the other women in the PREDO, and since 
birth register data suggests that none of the participating mothers had been diagnosed with mental disorders 
during pregnancy, the generalizability of the findings to more severe levels of maternal depression is question-
able. However, we did detect associations with the same indicator of placental morphology for both continu-
ously assessed antenatal depressive symptoms and for antenatal depressive symptoms exceeding a cutoff score 
for clinically relevant symptoms. Also the toddlers in the current study sample were younger than the other 
PREDO children at the time of completion of the CBCL, reflecting that sampling of placentas were added late to 
the PREDO study protocol, and some psychiatric problems assessed in the CBCL may not yet have developed to 
their full range of variation by 2–3 years of toddler age when psychiatric problems were assessed. Previous studies 
show that the level of internalizing problems increases between 1.5 and 5 years of age3,38. However, the age range 
of the current study sample is within the intended age range for the use of CBCL questionnaire (1.5–5 years), the 
scale has been validated for this whole age range38–40, and toddler age was not associated with toddler internal-
izing, externalizing, or total psychiatric problems in our study sample (r = 0.00, = −0.12, = −0.07, respectively, 
P-values ≥ 0.37).Yet, our findings need to be replicated also among older children.
Also, even though our explorative study indicated associations of the biological markers of placental mor-
phology with maternal antenatal depressive symptoms and toddler psychiatric problems, we do not know which 
physiological factors underlie these associations. As stated, maternal depression during pregnancy is associated 
with physiological changes in the functioning of the neurobiological stress system, oxidative stress and maternal 
nutrition6,9–14. As such changes are also associated with placental morphology41–45 and/or with psychiatric prob-
lems in the offspring46,47, these factors may have contributed to the associations found. Furthermore, we cannot 
rule out or confirm genetic explanations for our findings, with some genetic vulnerabilities contributing both 
to maternal depressive symptoms, aberrations in placental development and increased psychiatric problems in 
toddlers. Further studies are needed to elucidate the contributory effects of genetic and environmental factors to 
our findings.
On the other hand, we circumvented the weakness of conventional histologic villous classifications (differ-
entiation in stem, intermediate, and terminal villi) in the recognition of peripheral villous arborizations48–50 
by detecting SMA as a criterion of more central (stem villus like, SMA-positive) or peripheral (SMA-negative) 
villi. However, care should be taken since many SMA-positive villi did not have a larger calibre than many 
SMA-negative villi, making them histologically indiscernible. The term stem villus is thus not a synonym of 
term SMA-positive villus. By 2D section histology, recognizing differences in arborization topology is impossible; 
nodes cannot be recognized. The recently introduced 3D microscopy of peripheral villous trees48–50 can poten-
tially provide this information in further studies. Yet, our study has a novel focus, and its strengths include the 
Placental Morphology Criteria
Maternal Depressive Symptoms during Pregnancy
Model 1a Model 2b Model 3c
B(95% CI) p B(95% CI) p B(95% CI) p
Volume of SMA-positive villi per placenta 0.06(−0.15;0.28) 0.56 0.11(−0.11;0.33) 0.34 0.11(−0.13;0.34) 0.36
Volume of capillaries per SMA-positive villi per 
placenta 0.05(−0.17;0.27) 0.65 0.09(−0.13;0.31) 0.42 0.10(−0.14;0.34) 0.41
Volume of SMA-negative villi per placenta −0.09(−0.33;0.14) 0.43 −0.08(−0.31;0.14) 0.47 −0.06(−0.30;0.18) 0.64
Volume of capillaries per SMA-negative villi per 
placenta −0.13(−0.35;0.09) 0.26 −0.12(−0.34;0.10) 0.28 −0.10(−0.33;0.13) 0.40
Ratio of the distribution of stem villi to SMA-
negative villi 0.13(−0.09;0.34) 0.26 0.16(−0.06;0.38) 0.15 0.16(−0.07;0.40) 0.18
Villous barrier thickness of SMA-positive villi −0.10(−0.32;0.12) 0.36 −0.12(−0.35;0.11) 0.31 −0.06(−0.30;0.18) 0.60
Standard deviation of villous barrier thickness of 
SMA-positive villi (variability in thickness) −0.10(−0.31;0.13) 0.42 −0.08(−0.31;0.15) 0.49 −0.07(−0.32;0.18) 0.57
Villous barrier thickness of SMA-negative villi −0.17(−0.38;0.04) 0.12 −0.21(−0.43;0.01) 0.06 −0.14(−0.37;0.09) 0.22
Standard deviation of villous barrier thickness of 
SMA-negative villi (variability in thickness) −0.24(−0.46;−0.03) 0.03 −0.27(−0.50;−0.05) 0.02 −0.20(−0.43;0.04) 0.096
Table 2. Maternal Depressive Symptoms across Pregnancy and Placental Morphology. Unstandardized 
regression coefficients (B) and their 95% Confidence Intervals (CI) indicating standard deviation unit increase 
in placental morphology criteria per one standard deviation increase in maternal depressive symptoms across 
pregnancy from linear regression models where maternal depressive symptoms during pregnancy were used 
as predictors of placental morphology criteria. SMA = γ-smooth muscle actin. aModel 1 refers to unadjusted 
linear regression models. bModel 2 refers to linear regression models adjusted for gestation length, maternal age 
at delivery, education, pre-pregnancy body mass index and diabetic and hypertensive disorders in pregnancy. 
cModel 3 refers to linear regression models adjusted for model 2 covariates and maternal history of mental 
disorders before pregnancy.
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longitudinal design, the use of validated questionnaires on maternal and toddler psychopathology39,51–54, and the 
repeated, fortnightly assessments of maternal antenatal depressive symptoms.
In summary, our novel, explorative, hypothesis-generating study showed that maternal depressive symptoms 
during pregnancy were associated with lower variability in the thickness of the villous membrane of the periph-
eral villi in term placentas. This lower variability, indicating a reduction in the variability in the villous barrier 
thickness of SMA-negative villi, was also associated with subsequent toddler psychiatric problems. We propose 
that this lower heterogeneity in villous barrier thickness may compromise materno-fetal exchange, suggesting a 
possible role for altered placental structure in the fetal programming of mental disorders16.
Methods
Participants were from the prospective PREDO cohort55, which comprises 4777 pregnant women who gave birth 
to singleton live-born children in 2006–2010. These women were recruited to the study in early pregnancy at 
first ultrasound measurements at the antenatal clinics of ten study hospitals in Finland. All participating women 
Depressive Symptoms during 1st Pregnancy Trimester (n = 81) 2nd Pregnancy Trimester (n = 86) 3rd Pregnancy Trimester (n = 86)
Placental Criteria B(95% CI) p B(95% CI) p B(95% CI) p
Volume of SMA-positive villi per placenta
   Model 1 0.01(−0.22; 0.23) 0.97 0.05(−0.16; 0.26) 0.61 0.12(−0.09; 0.33) 0.27
   Model 2 0.06(−0.18; 0.31) 0.61 0.10(−0.11; 0.32) 0.33 0.14(−0.07; 0.36) 0.19
   Model 3 0.07(−0.18; 0.32) 0.59 0.10 (−0.12; 0.32) 0.37 0.15 (−0.08; 0.38) 0.21
Volume of capillaries per SMA-positive villi per placenta
   Model 1 0.00(−0.23; 0.23) 0.99 0.04(−0.17; 0.25) 0.68 0.11(−0.11; 0.32) 0.33
   Model 2 0.07(−0.17; 0.32) 0.55 0.09(−0.13; 0.30) 0.43 0.12(−0.10; 0.34) 0.27
   Model 3 0.09(−0.17; 0.34) 0.49 0.09(−0.14; 0.32) 0.43 0.14(−0.10; 0.37) 0.25
Volume of SMA-negative villi per placenta
   Model 1 0.05(−0.19; 0.29) 0.70 −0.07(−0.29; 0.14) 0.48 −0.16(−0.37; 0.06) 0.15
   Model 2 −0.01(−0.26; 0.25) 0.97 −0.05(−0.27; 0.17) 0.66 −0.13(−0.35; 0.09) 0.23
   Model 3 0.01(−0.26; 0.28) 0.94 0.02(−0.25; 0.21) 0.86 −0.11(−0.35; 0.13) 0.36
Volume of capillaries per SMA-negative villi per placenta
   Model 1 −0.02(−0.22; 0.26) 0.88 −0.12(−0.33; 0.09) 0.27 −0.18(−0.40; 0.03) 0.09
   Model 2 −0.07(−0.32; 0.18) 0.59 −0.08(−0.29; 0.13) 0.46 −0.15(−0.36; 0.07) 0.17
   Model 3 −0.06(−0.32; 0.20) 0.66 −0.06(−0.28; 0.17) 0.61 −0.13(−0.37; 0.10) 0.26
Ratio of the distribution of stem villi to SMA-negative villi
   Model 1 0.01(−0.23; 0.25) 0.92 0.11(−0.10; 0.32) 0.30 0.20(−0.01; 0.41) 0.07
   Model 2 0.09(−0.16; 0.35) 0.47 0.14(−0.07; 0.36) 0.19 0.21(−0.01; 0.42) 0.06
   Model 3 0.09(−0.17; 0.36) 0.48 0.14(−0.09; 0.36) 0.23 0.22(−0.02; 0.45) 0.07
Villous barrier thickness of SMA-positive villi
   Model 1 −0.09(−0.33; 0.15) 0.45 −0.06(−0.27; 0.15) 0.58 −0.14(−0.35; 0.08) 0.20
   Model 2 −0.13(−0.39; 0.13) 0.33 −0.07(−0.29; 0.15) 0.52 −0.15(−0.38; 0.07) 0.18
   Model 3 −0.08(−0.34; 0.18) 0.55 −0.03(−0.25; 0.20) 0.82 −0.10(−0.34; 0.14) 0.40
Standard deviation of villous barrier thickness of SMA-positive villi (variability in thickness)
   Model 1 −0.06(−0.30; 0.19) 0.65 −0.07(−0.28; 0.14) 0.49 −0.10(−0.32; 0.11) 0.34
   Model 2 −0.06(−0.32; 0.21) 0.67 −0.07(−0.29; 0.16) 0.56 −0.10(−0.33; 0.13) 0.38
   Model 3 −0.04(−0.32; 0.23) 0.76 −0.06(−0.29; 0.18) 0.63 −0.10(−0.34; 0.15) 0.45
Villous barrier thickness of SMA-negative villi
   Model 1 −0.16(−0.40; 0.08) 0.18 −0.16(−0.36; 0.04) 0.12 −0.17(−0.38; 0.04) 0.11
   Model 2 −0.25(−0.50; 0.00) 0.052 −0.19(−0.40; 0.03) 0.08 −0.19(−0.40; 0.02) 0.08
   Model 3 −0.19(−0.44; 0.06) 0.14 −0.12(−0.34; 0.09) 0.26 −0.11(−0.34; 0.12) 0.35
Standard deviation of villous barrier thickness of SMA-negative villi (variability in thickness)
   Model 1 −0.24(−0.48; −0.01) 0.04 −0.20(−0.40; 0.01) 0.06 −0.22(−0.43; −0.01) 0.04
   Model 2 −0.33(−0.58; −0.08) 0.01 −0.23(−0.44; −0.01) 0.05 −0.23(−0.45; −0.01) 0.04
   Model 3 −0.27(−0.53; −0.02) 0.04 −0.15(−0.37; 0.07) 0.18 −0.14(−0.37; 0.10) 0.24
Table 3. Maternal Trimester-Specific Prenatal Depressive Symptoms and Placental Morphology. SMA = γ-smooth 
muscle actin. Unstandardized regression coefficients (B) and their 95% Confidence Intervals (CI) from linear 
regression models, indicating standard deviation unit increase in placental morphology criteria per one standard 
deviation increase in mean maternal depressive symptoms during each pregnancy trimester. Regression Model 1 is 
unadjusted. Model 2 is adjusted for maternal age and education level, pre-pregnancy body mass index, hypertensive 
and diabetic disorders in pregnancy and gestation length. Model 3 is adjusted for Model 2 covariates and maternal 
history of mental disorders before pregnancy.
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signed informed consents. The PREDO study protocol was approved by Helsinki and Uusimaa Hospital District 
ethical committees55. The PREDO study has been conducted in accordance with the declaration of Helsinki.
Placental biopsy collection was introduced to the study protocol in 2009. Samples were collected at two mater-
nity clinics in Helsinki, Finland. Placental morphology data were available from 96 mother-child dyads with 
infants born at term in 2009–2010. Eight had neither maternal nor child psychiatric data and were excluded from 
this study.
Our final study sample thus comprises 88 participants. Of them, 86 had data on maternal depressive symptoms 
during pregnancy and 60 on toddler psychiatric problems. Compared to other PREDO mothers, the mothers 
participating in this study had less depressive symptoms during the third pregnancy trimester (MD = −0.24 SD 
units: 95% CI = −0.45; −0.02: P = 0.03). Compared to non-participating PREDO children, the participating tod-
dlers were younger at childhood follow-up (MD = −1.37 years: 95% CI = −1.30; −1.44: P < 0.001). There were 
no differences between participating and non-participating mothers or toddlers in other assessed characteristics 
(maternal age, education level, BMI, diabetes and hypertension in pregnancy, history of physician-diagnosed 
mental disorders before pregnancy, depressive symptoms at other time points, gestation length or toddler sex or 
psychiatric problems; P-values ≥ 0.08).
Placental Morphology. Two placenta samples with an edge length of ~1 cm and full depth of the placenta 
were taken from each placenta after birth without a preference for specific placental sites from macroscopically 
unsuspicious areas, then routinely fixed in formaldehyde. After fixation lasting at least 24 hours, the samples were 
routinely dehydrated in an alcohol step gradient and embedded in paraffin. For morphometric analysis, these 
paraffin blocks were transferred to LMU Munich, Germany.
Paraffin samples were sectioned as 4–6 micrometres thick sections and placed on super frost object slides 
(SuperFrost plus, Thermofisher, Munich, Germany). All slides were deparaffinized through xylene and a step-
wise ethanol gradient. Immunohistochemical double labelling was performed, comprising an antibody to CD34 
(labelling of fetal endothelium) and to SMA (labelling of perivascular myofibroblast-like cells)19. Peroxidase with 
DAB as substrate (anti-CD34, brown reaction product) and β-galactosidase with X-Gal as substrate (anti-SMA, 
indigo-blue reaction product) were used for differential visualization in brightfield microscopy. Nuclei were coun-
terstained with haematoxylin. The sequence of steps was empirically optimized such that the anti-CD34 detection 
was always carried out first and completely. Both immunohistochemical sequences used streptavidin-enzyme 
conjugates. Cross reactivity due to streptavidin use in both sequences was excluded by controls included in 
the second immunohistochemical sequence (anti-SMA). SMA-detection was used for classification of villi 
based on recommendations in the literature49. After peroxidase detection, anti-SMA detection was performed. 
Supplementary Tables S3–S4 give full details of the immunohistochemical reaction steps. Finally, the nuclei 
were counterstained with haematoxylin and the slides mounted with coverslips (Kaiser’s glycerol jelly, Merck, 
Darmstadt, Germany). All object slides were stored at 4 °C prior to microscopic evaluations.
We examined nine placental morphology criteria: the volumes of SMA-positive and SMA-negative (periph-
eral) villi per placenta, the volume of capillaries per SMA-positive and SMA-negative villi per placenta, the 
ratio of volumes of SMA-positive to SMA-negative villi, the villous barrier thicknesses (distance from the 
outer trophoblast to the endothelium of the fetal vessels inside the villous tree) and the SDs of villous barrier 
thicknesses stratified by SMA-positive and SMA-negative villi. The volume criteria are expressed in millilitres 
and were calculated by dividing the assessed criterion by placental weight (grams). Volume estimates were 
performed according to the Cavalieri principle on single thin (4–6 micrometres) histological sections using 
a computerized stereology workstation, which comprised a modified light microscope (Axioskop;Zeiss) with 
motorized specimen stage for automatic sampling [MBF Bioscience, Williston, VT, United States of America 
Figure 2. Immunohistochemical double labeling of perivascular sheath and fetal villous endothelium. (A) 
Shows an example of a γ-smooth-muscle-actin(SMA)-positive villus (indigo-blue in perivascular position; 
white arrows). The endothelium of fetal vessels is labelled (CD34: brown; black arrows), the villous stroma 
marked by asterisks and the trophoblast (bluish nuclei; shaded arrows) visible. (B) Exemplifies a SMA-negative 
villus (no SMA reactivity in perivascular position). The endothelium of fetal vessels is labelled (CD34: brown; 
black arrows), villous stroma marked by asterisks and trophoblast (bluish nuclei; shaded arrows) visible. Red 
arrow heads label vasculo-syncytial-membrane spots. (A) Scale bar is 25 µm and valid for (B).
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(USA)] and stage controller [Type MAC 6000, Ludl Electronics, Hawthorne, New York, USA], focus encoder 
(Type MT 1271, Heidenhain, Germany), CCD colour video camera (1600H 3 1200 V pixels, MBF Bioscience, 
Williston, VT, USA) and stereology software (Stereo Investigator version 10;MBF Bioscience). This approach 
delivers volume fractions as raw data, which were stratified to the villous tree substructures (villous stroma, 
vessel lumen, endothelium, and syncytiotrophoblast), intervillous space and fibrinoid. Then, absolute volumes 
were calculated by multiplying volume fractions with total placental volume [placental volume is defined by 
placental weight divided by the density of placental tissue (1.03 g/millilitre)]. To determine villous barrier 
thickness, we used the Nearest Neighbor option in the stereology software (Stereo Investigator version 10, MBF 
Bioscience). The villous barrier thickness is expressed in micrometres. Figures 2 and 3 show illustrations of the 
placental morphology criteria measurements.
Maternal Depressive Symptoms. The women assessed their depressive symptoms fortnightly up to 14 
times during pregnancy from pregnancy weeks + days 12 + 0/13 + 6 until delivery or 38 + 0/39 + 6 pregnancy 
weeks + days with the Center for Epidemiological Studies Depression Scale (CES-D)53, which comprises 20 
Toddler Psychiatric Problem Scale Total Problems Internalizing Problems Externalizing Problems
Placental Morphology Structure B(95% CI) p B(95% CI) p B(95% CI) p
Volume of SMA-positive villi per placenta
   Model 1 0.02(−0.23; 0.27) 0.88 −0.03(−0.27; 0.19) 0.77 −0.05(−0.31; 0.21) 0.70
   Model 2 −0.00(−0.27; 0.27) 0.98 −0.05(−0.29; 0.19) 0.69 −0.08(−0.36; 0.20) 0.58
   Model 3 −0.04(−0.20; 0.27) 0.76 −0.02(−0.23; 0.20) 0.88 −0.04(−0.29; 0.22) 0.78
Volume of capillaries per SMA-positive villi per placenta
   Model 1 0.02(−0.23; 0.27) 0.90 −0.03(−0.25; 0.20) 0.81 −0.05(−0.31; 0.21) 0.68
   Model 2 −0.02(−0.29; 0.25) 0.87 −0.07(−0.30; 0.17) 0.59 −0.08(−0.36; 0.20) 0.58
   Model 3 −0.01(−0.25; 0.23) 0.92 −0.05(−0.27; 0.16) 0.63 −0.08(−0.33; 0.17) 0.54
Volume of SMA-negative villi per placenta
   Model 1 −0.05(−0.32; 0.23) 0.72 0.04(−0.21; 0.29) 0.75 −0.11(−0.39; 0.18) 0.46
   Model 2 −0.12(−0.44; 0.19) 0.44 −0.02(−0.30; 0.26) 0.88 −0.20(−0.52; 0.13) 0.22
   Model 3 0.05(−0.22; 0.32) 0.71 0.13(−0.11; 0.37) 0.28 −0.03(−0.31; 0.26) 0.84
Volume of capillaries per SMA-negative villi per placenta
   Model 1 −0.09(−0.35; 0.18) 0.51 −0.00(−0.24; 0.24) 0.99 −0.12(−0.40; 0.15) 0.36
   Model 2 −0.20(−0.51; 0.11) 0.21 −0.09(−0.37; 0.19) 0.51 −0.25(−0.57; 0.07) 0.13
   Model 3 0.00(−0.26; 0.25) 0.98 0.08(−0.15; 0.31) 0.49 −0.06(−0.33; 0.21) 0.67
Ratio of the distribution of SMA-positive villi to SMA-negative villi
   Model 1 0.02(−0.23; 0.27) 0.88 −0.07(−0.30; 0.16) 0.54 0.00(−0.26; 0.26) 0.99
   Model 2 0.03(−0.25; 0.31) 0.82 −0.06(−0.30; 0.19) 0.64 0.01 (−0.27; 0.30) 0.92
   Model 3 0.01(−0.23; 0.25) 0.92 −0.08(−0.29; 0.14) 0.48 −0.00(−0.26; 0.25) 0.97
Villous barrier thickness of SMA-positive villi
   Model 1 −0.08(−0.36; 0.21) 0.60 −0.12(−0.37; 0.14) 0.36 0.02(−0.27; 0.31) 0.89
   Model 2 −0.11(−0.44; 0.21) 0.48 −0.19(−0.47; 0.09) 0.18 0.01(−0.33; 0.35) 0.95
   Model 3 0.02(−0.26; 0.29) 0.91 −0.04(−0.29; 0.21) 0.75 0.10(−0.19; 0.39) 0.49
Standard deviation of villous barrier thickness of SMA positive villi (variability in thickness)
   Model 1 −0.02(−0.28; 0.23) 0.86 0.02(−0.21; 0.25) 0.87 −0.05(−0.31; 0.21) 0.70
   Model 2 −0.05(−0.32; 0.22) 0.71 −0.01(−0.25; 0.23) 0.93 −0.07(−0.35; 0.21) 0.62
   Model 3 0.06(−0.19; 0.31) 0.63 0.09(−0.13; 0.31) 0.40 0.02(−0.24; 0.27) 0.91
Villous barrier thickness of SMA-negative villi
   Model 1 −0.14(−0.42; 0.13) 0.31 −0.18(−0.42; 0.07) 0.16 −0.00(−0.29; 0.28) 0.98
   Model 2 −0.16(−0.45; 0.12) 0.26 −0.20(−0.45; 0.05) 0.12 −0.01(−0.31; 0.29) 0.93
   Model 3 −0.08(−0.34; 0.19) 0.56 −0.12(−0.36; 0.12) 0.31 0.05(−0.23; 0.33) 0.71
Standard deviation of villous barrier thickness of SMA-negative villi (variability in thickness)
   Model 1 −0.34(−0.60; −0.07) 0.01 −0.32(−0.56; −0.08) 0.01 −0.20(−0.48; 0.09) 0.17
   Model 2 −0.35(−0.63; −0.07) 0.01 −0.34(−0.59; −0.10) 0.01 −0.21(−0.51; 0.09) 0.16
   Model 3 −0.29(−0.54; −0.03) 0.03 −0.28(−0.51; −0.05) 0.02 −0.15(−0.43; 0.13) 0.28
Table 4. Placental Morphology and Toddler Psychiatric Problems. Unstandardized regression coefficients (B) and 
their 95% Confidence Intervals (CI) indicating standard deviation unit increase in toddler psychiatric problems 
per standard deviation increase in placental morphology criteria from linear regression models where placental 
morphology criteria were used to predict toddler psychiatric problems. SMA = γ-smooth muscle actin. Model 1 
is unadjusted. Model 2 is adjusted for toddler’s age and sex, gestation length, maternal age at childbirth, education, 
pre-pregnancy BMI and maternal diabetic and hypertensive disorders in pregnancy. Model 3 is adjusted for maternal 
depressive symptoms concurrently to assessing her child’s psychiatric problems.
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questions on the frequency of depressive symptoms during the preceding week. CES-D sum-scores range from 
0 to 60. Higher scores indicate more depressive symptoms. The CES-D cutoff score of ≥16 indicates risk for clin-
ical depression53. The CES-D has excellent psychometric properties52–54,56,57, and it has been validated also among 
pregnant women57,58. In our sample, the CES-D had high internal consistency (Cronbach’s α varying from =0.85 
to =0.93).
Toddler Psychiatric Problems. When the toddlers were 1.9–3.1 years old, the mothers completed the 
Child Behavior Checklist for Ages 1½-5 (CBCL1½-5) which is a well-validated and very widely used scale on 
child psychiatric problems39,51. It comprises 99 items, rated from 0 to 2. Higher t-scores reflect more problems 
on the CBCL1½-5 main scales of internalizing, externalizing and total problems51, on the seven CBCL1½-5 
Syndrome Scales and on the five CBCL1½-5 Diagnostic and Statistical Manual for Mental Disorders-Fourth 
Edition-oriented scales51.
Covariates. Information on maternal pre-pregnancy height and weight, of which pre-pregnancy BMI (kilo-
grams/metres2) was calculated, maternal diabetes and/or hypertension in pregnancy (gestational and type 1 dia-
betes, preeclampsia, chronic and gestational hypertension; any vs. none), maternal age at delivery, toddler sex, 
birth date and gestation length was extracted from the Finnish Medical Birth Register and patient case records. 
Maternal history of physician-diagnosed mental disorders (depression, panic disorder, schizophrenia, other psy-
chosis, other mental disorder) before pregnancy (no/yes; n = 80; 6 mothers with missing data were dummy-coded 
to an own category for regression analysis) and education level (primary/secondary vs. tertiary) was self-reported 
during pregnancy. Mothers assessed their depressive symptoms at toddler follow-up with the Beck Depression 
Inventory-II59. Toddler age at follow-up was calculated by subtracting birth date from CBCL1½-5 completion date.
Figure 3. An illustration of the villous membrane thickness measurement principle. (A,B) Show examples 
of SMA-negative villi with endothelium labelled by CD34-reactivity (brown reaction product). (C,D) Show 
examples of SMA-positive villi (indigo-blue reaction product in perivascular position) with endothelium 
labelled by CD34-reactivity (brown reaction product). (A–D) We measured membrane thickness with the 
Nearest Neighbor analysis and the shortest distance (red line) from the trophoblast to the fetal endothelium by 
increasing a circle (red) from the trophoblast surface until first intersection with the endothelium. Exemplary 
measurement positions are marked with black arrows. Scale bar is 25 µm.
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Statistical Analyses. To account for skewness and improve linear model fitting, the maternal depressive 
symptom scores, volumes of SMA-positive villi per placenta- and capillaries per SMA-positive villi per placenta, 
the villous barrier thickness of SMA-negative villi and the SD of villous barrier thickness of SMA-positive villi 
were square-root transformed and maternal pre-pregnancy body mass index and the placental ratio of the distri-
bution of SMA-positive villi to SMA-negative villi, the villous barrier thickness of SMA-positive villi and the SD of 
villous barrier thickness of SMA-negative villi were rank-normalized according to Blom’s formula. All continuous 
variables are expressed in SD units (mean = 0: SD = 1).
We examined the associations between maternal depressive symptoms and placental morphology with linear 
regression models. In these models, trimester-weighted mean maternal depressive symptoms across pregnancy 
(mean value calculated from the value in first trimester and mean values across second and third trimesters) and 
mean scores during each pregnancy trimester and depressive symptoms above the clinical cutoff (≥16 across 
pregnancy or 0, 1, or 2/3 times across pregnancy trimesters) predicted placental morphology criteria. We present 
unstandardized regression coefficients (B) and 95% CI in SD units from unadjusted regression models, regression 
models adjusted for maternal age, education, BMI, diabetes and hypertension in pregnancy and gestation length, 
and models adjusted further for maternal history of physician-diagnosed mental disorders before pregnancy.
We tested whether placental morphology criteria predicted toddler internalizing, externalizing and total prob-
lems using linear regression. We present B and 95% CI from unadjusted models, models adjusted for toddler age 
and sex, gestation length, maternal age, education, BMI, diabetes and hypertension in pregnancy, and models 
adjusted for maternal depressive symptoms concurrent to rating toddler’s psychiatric problems. To specify any 
possible effects of toddler psychiatric problems, we examined the syndrome- and DSM-IV-oriented CBCL as sec-
ondary outcomes for those placental criterion that showed significant associations with the main scales. The asso-
ciations with these CBCL subscales were examined with tobit regressions, since these scales are left-censored51.
Data Availability. The datasets generated during and/or analysed during the current study are not publicly 
available due to prohibitions by national laws since the data include patient report data. However, the datasets 
generated during and/or analysed during the current study are available from the corresponding author on rea-
sonable request in completely anonymized form. Due to the sensitive nature of the patient report data, data 
requests may require further approval by the PREDO Study Board, that also enables collaboration in PREDO data 
analysis through specific study proposals55.
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